- Home
- IDN vs TARA Comparison
IDN vs TARA Comparison
Compare IDN & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDN
- TARA
- Stock Information
- Founded
- IDN 1994
- TARA N/A
- Country
- IDN United States
- TARA United States
- Employees
- IDN N/A
- TARA N/A
- Industry
- IDN Computer Software: Prepackaged Software
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IDN Technology
- TARA Health Care
- Exchange
- IDN Nasdaq
- TARA Nasdaq
- Market Cap
- IDN 120.5M
- TARA 126.5M
- IPO Year
- IDN 1999
- TARA N/A
- Fundamental
- Price
- IDN $5.35
- TARA $2.86
- Analyst Decision
- IDN Strong Buy
- TARA Strong Buy
- Analyst Count
- IDN 3
- TARA 7
- Target Price
- IDN $5.83
- TARA $20.67
- AVG Volume (30 Days)
- IDN 481.3K
- TARA 452.7K
- Earning Date
- IDN 08-07-2025
- TARA 08-05-2025
- Dividend Yield
- IDN N/A
- TARA N/A
- EPS Growth
- IDN N/A
- TARA N/A
- EPS
- IDN N/A
- TARA N/A
- Revenue
- IDN $20,211,000.00
- TARA N/A
- Revenue This Year
- IDN $9.35
- TARA N/A
- Revenue Next Year
- IDN $13.05
- TARA N/A
- P/E Ratio
- IDN N/A
- TARA N/A
- Revenue Growth
- IDN 4.55
- TARA N/A
- 52 Week Low
- IDN $1.92
- TARA $1.60
- 52 Week High
- IDN $6.49
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- IDN 59.07
- TARA 43.02
- Support Level
- IDN $5.21
- TARA $3.12
- Resistance Level
- IDN $5.97
- TARA $3.10
- Average True Range (ATR)
- IDN 0.39
- TARA 0.19
- MACD
- IDN -0.10
- TARA -0.01
- Stochastic Oscillator
- IDN 29.01
- TARA 17.19
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).